Select Page

SSM Health Fond du Lac Regional Clinic physiatrist offering leading-edge tendon procedure, bringing patients faster recovery

Christopher Ng, MD, an SSM Health Fond du Lac Regional Clinic physiatrist, is now offering the Tenex Health TX® system (Tenex) at SSM Health St. Agnes Hospital, bringing innovative treatment to patients in the Fond du Lac area who are experiencing chronic tendon pain.

Tenex is an FDA-cleared, minimally invasive device for treatment of soft tissue, hard tissue and diabetic foot ulcers. Common treatment sites include the shoulder, elbow, hip/gluteus, knee, ankle, foot/plantar fascia, bone spurs and calcific deposits in tendon. For individuals who have already explored conservative treatments and experienced pain for three months or more, they may be a candidate for treatment with Tenex.

“Many of my patients suffer from persistent tendon pain that interferes with work, exercise, or daily function,” according to Dr. Ng. “Tenex allows us to treat the source of the pain – not just mask it – with real-time ultrasound guidance and advanced ultrasonic technology.”

Developed in collaboration with the Mayo Clinic, Tenex offers a clinically proven, image-guided solution that removes the source of pain for patients who have not responded to conservative treatments such as rest, ice and physical therapy.

Tenex offers patients many benefits, including:

  • Ultrasound-guided precision: Uses real-time imaging to accurately visualize and target the damaged tendon tissue.
  • Targeted ultrasonic treatment: A one-time procedure that removes only the diseased tissue while preserving healthy tendon.
  • Quick and convenient: Performed in an outpatient setting.
  • Minimally invasive: Requires no stitches – only a small adhesive bandage.
  • Opioid-free recovery: Removes the need for opioids or prolonged physical therapy.
  • Faster return to activity: Most patients resume normal function within six to 12 weeks, significantly faster than the more than six months typically needed after open surgery.

Tendonitis, often caused by repetitive motion or injury, affects more than 24 million people each year in the United States. An estimated two to three million of those individuals progress to tendinosis, a degenerative condition that can be effectively treated with Tenex.

Supported by over 100 independent, peer-reviewed studies and articles in medical journals, with more than 200,000 procedures performed, Tenex has emerged as a standard of care in musculoskeletal medicine, proving ≥85% clinical efficacy in soft tissue

For more information about Tenex or to schedule a consultation, call 920-926-8571.

A male doctor

Christopher Ng, MD